Table 2 Multiple linear regression for the impact of TOZ on the mean difference in erythrocyte sedimentation rate (ESR) level (ESR baseline-ESR follow−up)
variable | Parameter Estimates | p-value | 95% Confidence Limits | |
|---|---|---|---|---|
TOZ vs. ADM or ETC | 11.31884 | 0.0065* | 3.22486 | 19.41283 |
Age | -0.14195 | 0.3154 | -0.42052 | 0.13661 |
Female vs. male | 9.47349 | 0.1624 | -3.86311 | 22.81009 |
Treatment Duration | -1.77115 | 0.0261* | -3.32801 | -0.21429 |
Disease Duration | 0.27866 | 0.3319 | -0.28717 | 0.84450 |
Baseline CRP | 0.19126 | 0.3165 | -0.18489 | 0.56741 |
Baseline ESR | 0.44103 | < 0.0001* | 0.30911 | 0.57296 |
number of comorbidities | 0.49072 | 0.3807 | -0.61261 | 1.59405 |
glucocorticoids | -15.57322 | 0.0064* | -26.68695 | -4.45948 |